Author Credentials

Mose July, MD, Prasanna Santhanam, MD, Jenan Gabi, MD, Rodhan A. Khthir, MD




Background: Hyperglycemia is common in critically ill patients and has been associated with poor outcomes. The effect of hypothermia, whether induced or spontaneous, on insulin resistance and hyperglycemia is not well understood and sometimes overlooked.

Objectives: To review the literature on glucose metabolism and insulin resistance in patients treated with therapeutic Hypothermia (TH) after sudden cardiac arrest (SCA). And also to present knowledge about the possible effects of hypothermia on glycemic control and insulin sensitivity.

Methods: we present an example of extreme insulin resistance during the period of therapeutic hypothermia in a patient who was admitted after a sudden cardiac Arrest. Literature review was conducted as a Medline/PubMed search. Studies were assessed regarding designs, primary and secondary efficacy parameters on TH after sudden cardiac arrest and effects on glucose metabolism.

Results: A 68-year-old male who was admitted after SCA was noted to have extreme insulin resistance during TH which completely resolved during the rewarming phase of TH. No randomized, controlled trials were found in the Medline search. Two studies found that there was an increase in insulin resistance during TH especially during the cooling phase, whereas three studies found no direct association between TH and blood glucose levels.

Conclusion: There is a possible association between TH and a reversible form of insulin resistance. More studies are needed. Patients who are treated with TH after SCA may present a challenge in glucose management.

Conflict(s) of Interest

The authors of this manuscript have not had a relevant duality of interest with a company whose products or services are directly related to the subject matter of their manuscript.

References with DOI

1. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. The New England journal of medicine. 2002;346(8):557-63. https://doi.org/10.1016/s1062-1458(02)00737-7

2. D.G. Beiser, G.E. Carr, D.P. Edelson, M.A. Peberdy, T.L. Hoek. Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation. Resuscitation, 2009;(80):624–630. https://doi.org/10.1016/j.resuscitation.2009.02.011

3. S.H. Kim, S.P. Choi, K.N. Park, S.J. Lee, K.W. Lee, T.O. Jeong, et al. Association of blood glucose at admission with outcomes in patients treated with therapeutic hypothermia after cardiac arrest. Am J Emerg Med. 2014;(32): 900–904. https://doi.org/10.1016/j.ajem.2014.05.004

4. N. Nielsen, K. Sunde, J. Hovdenes, R.R. Riker, S. Rubertsson, P. Stammet, et al. Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med. 2011; (39):57–64. https://doi.org/10.1097/ccm.0b013e3181fa4301

5. Nurmi J, Boyd J, Anttalainen N, Westerbacka J, Kuisma M. Early increase in blood glucose in patients resuscitated from out-of-hospital ventricular fibrillation predicts poor outcome. Diabetes Care. 2012;(35):510–512. https://doi.org/10.2337/dc11-1478

6. Polderman K. Application of therapeutic hypothermia in the intensive care unit. Intens Care Med. 2004;30:757–769. https://doi.org/10.1007/s00134-003-2151-y

7. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of therapeutic hypothermia in comatose out-of hospital cardiac arrest survivors. Acta Anaesthesiol Scand. 2006; 50:1277– 1283. https://doi.org/10.1111/j.1399-6576.2006.01147.x

8. Kim et al. Time to reach target glucose level and outcome after cardiac arrest patients treated with t herapeutic hypothermia. J Cri Care. 2015;Dec;30 (6) 1204-9. https://doi.org/10.1016/j.jcrc.2015.08.011

9. Ettleson MD, Arguello V, Wallia A, Arguelles L, Bernstein RA, Molitch ME. Hyperglycemia and insulin resistance in cardiac arrest patients treated with moderate hypothermia. J. Clin. Endocrinol. Metab. 2014;99(10):E2010-4. https://doi.org/10.1210/jc.2014-1449

10. Sah Pri A, Chase JG, Pretty CG, Shaw GM, Preiser JC, Vincent JL, et al. Evolution of insulin sensitivity and its variability in out-of-hospital cardiac arrest (OHCA) patients treated with hypothermia. Critical care. 2014;18(5):586. https://doi.org/10.1186/preaccept-4717752591304980

11. Cueni-Villoz N, Devigili A, Delodder F, Cianferoni S, Feihl F, Rossetti AO, et al. Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest. Critical care medicine. 2011;39(10):2225-31. https://doi.org/10.1097/ccm.0b013e31822572c9

12. Forni AA, Rocchio MA, Szumita PM, Anger KE, Avery KR, Scirica BM. Evaluation of glucose management during therapeutic hypothermia at a Tertiary Academic Medical Center. Resuscitation. 2015 Apr;89:64-9. 34 https://doi.org/10.1016/j.resuscitation.2015.01.002